COVID-19 Vaccine Acceptance in India: Early Experiences and lessons From Adult Immunization, H1N1 Pandemic and Seasonal Influenza Vaccination
Keywords:
COVID-19, Vaccine, Vaccine Acceptance.Abstract
With no definite therapeutic or preventive drug against COVID-19 virus, vaccine is critical to disrupt the pandemic. Two vaccines have received emergency use authorization in America and Europe and two vaccine in India. Indian introduced COVID-19 vaccination on January 16, 2021. Despite severe disruption of the lifestyle, socioeconomic activities and ongoing restrictions, vaccine hesitancy is anticipated. While the vaccine introduction is in progress, the vaccine hesitancy needs to be considered based on the past experiences on pandemic and adult immunization drives. The initial experiences in India has been uneven with lower performance in some progressive states. Special targeted efforts are needed to tackle the vaccine hesitancy and improve public confidence for effective
implementation.
References
US Food and Drug Administration. FDA Takes Key Action in Fight against COVID-19 by Issuing Emergency Use Authorization for First COVID-19 Vaccine (News Release)
Ministry of Health and Family Welfare (MOHFW). COVID-19 Vaccines Operational Guidelines (Draft). Ministry of Health & Family Welfare Government of India [2020].
Kannan R. Coronavirus | Study warns of COVID-19 vaccine hesitancy.
Express News Service. Nearly 70% Indians unwilling to take Covid-19 vaccine, finds study. The Indian Express
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, et al. “A global survey of potential acceptance of a COVID-19 vaccine”. Nat Med 27(2020): 225-228.
Malik AA, McFadden SM, Elharake J, Omer SB. “Determinants of COVID-19 vaccine acceptance in the US”. E Clinical Medicine. 26(2020):100495.
Funk C, Tyson A. Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases. Still about two-in-ten ‘pretty certain’ they won’t get vaccine – even when there’s more information.
Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, et al. “Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination”. JAMA Netw Open 3(2020):e2025594.
Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, et al. “Vaccine Hesitancy: The Next Challenge in the Fight Against COVID-19”.Research Square(2020).
Al-Mohaithef M, Padhi BK. “Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey”. J Multi discip Health 13(2020):1657-1663.
Porter RM, Goldin S, Lafond KE, Hedman L, Ungkuldee M, et al. “Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic”. Vaccine 38(2020):1152–1159.
World Health Organisation. Main operational lessons learnt from the WHO pandemic influenza A (H1N1) vaccine deployment initiative: Report of a WHO meeting held in Geneva, Switzerland, 13–15 December 2010
Rambhia KJ, Watson M, Sell TK, Waldhorn R, Toner E, et al. “Mass Vaccination for the 2009 H1N1 Pandemic: Approaches, Challenges, and Recommendations”. Biosecurity Bioterrorism Biodefense Strategy Pract Sci 8(2010):321-330.
Ropero-Álvarez AM, Whittembury A, Kurtis HJ, Dos Santos T, Danovaro-Holliday MC, et al. “Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean”. Vaccine 30(2012):916-921.
Seale H, Kaur R, Wang Q, Yang P, Zhang Y, et al. “Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China”. Vaccine 29(2011):1605- 1610.
La Torre G, Di Thiene D, Cadeddu C, Ricciardi W, Boccia A. “Behaviours regarding preventive measures against pandemic H1N1 influenza among Italian healthcare workers, October 2009”. Euro 14(2009):49.
Chor JSY, Ngai KL, Goggins WB, Wong MCS, Wong SYS, Lee N, et al. “Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys”. BMJ 339(2009):3391- 3391.
Thoon KC, Chong CY. “Survey of healthcare workers’ attitudes, beliefs and willingness to receive the 2009 pandemic influenza A (H1N1) vaccine and the impact of educational campaigns”. Ann Acad Med Singapore 39(2010):307-306.
Esteves-Jaramillo A, Omer SB, Gonzalez-Diaz E, Salmon DA, Hixson B, et al. “Acceptance of a vaccine against novel influenza A (H1N1) virus among health care workers in two major cities in Mexico”. Arch Med Res 40(2009):705-711.
Vírseda S, Restrepo MA, Arranz E, Magan-Tapia P, Fernandez- Ruiz M, et al. “Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital”. Vaccine 28(2010):4751-4757.
Rachiotis G, Mouchtouri VA, Kremastinou J, Gourgoulianis K, Hadjichristodoulou C. “Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece”. Euro Surveill Bull 15(2010):
Torun SD, Torun F. “Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase”. Vaccine. 28(2010):5703-5710.
Holla VN, Borker S. “H1N1 Newer Vaccine Usage: Experiences from Karnataka State”. Indian J Community Med 37(2012):134-136.
Bali NK, Ashraf M, Ahmad F, Khan UH, Widdowson M-A,et al. “Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India: Healthcare workers and influenza vaccination”. Influenza Other Respir Viruses 7(2013):540-545.
Hadaye RS, Manapurath RM, Gadapani BP. “Awareness and acceptance of H1N1 vaccination among physicians: Experience of 2017 vaccination campaign”. J Educ Health Promot 8 (2019):82.
Sundaram N, Purohit V, Schaetti C, Kudale A, Joseph S, et al. “Community awareness, use and preference for pandemic influenza vaccines in Pune, India”. Hum Vaccines Immunother 11(2015):2376-2388.
Suresh PS, Thejaswini V, Rajan T. “Factors associated with 2009 pandemic influenza A (H1N1) vaccination acceptance among university students from India during the post-pandemic phase”. BMC Infect Dis 11(2011):205.
Fox M. U.S. has 71 million unused flu vaccine doses.
Mascarenhas A. 7 mn unused doses of H1N1 vaccine to be destroyed. The Indian Express
Vaccines against influenza WHO position paper – November 2012. Releve Epidemiol Hebd.
Ortiz JR, Perut M, Dumolard L, Wijesinghe PR, Jorgensen P, et al. “A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization”. Vaccine 34(2016):5400-5405.
Centres for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2019–20 Influenza Season. DOI: 10.47755/J Vaccines Immuno Pathol (2021): 1; 001-006
Lu P-J, Hung M-C, O’Halloran AC, Ding H, Srivastav A, et al. “Seasonal Influenza Vaccination Coverage Trends Among Adult Populations, U.S., 2010-2016”. Am J Prev Med 57(2019):458-469.
Portero de la Cruz S, Cebrino J. “Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006– 2017)”. Vaccines 8(2020):327.
Wang Y, Cheng M, Wang S, Wu F, Yan Q, et al. “Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017”. BMC Public Health 20(2020):359.
Geneev C, Mathew N, Jacob JJ. “Vaccination Status, Knowledge, and Acceptance of Adult Vaccinations against Respiratory Illness among Patients with Type 2 Diabetes Mellitus”. Indian J Endocrinol Metab 22(2018):280-282.
Koul PA, Ali S, Mir H, Ahmad SJ, Bhat SA, Bhat MA. “Influenza vaccination in north Indian patients with heart failure”. Indian Heart J 69(2017):28-31.
Sharma NC. Why government’s adult immunisation policy is not taking off. Mint (e-paper).
Dey S. UP leads in total vaccine doses, Karnataka in most 2nd shots. The Times of India.
